Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

By de la Fuente-Fernández Raúl   Sossi Vesna   Huang Zhigao   Furtado Sarah   Lu Jian-Qiang   Calne Donald B.   Ruth Thomas J.   Stoessl A. Jon  

Brain, Vol. 127, Iss. 12, 2004-12 ,pp. : 2747-2754

Oxford University Press

Access to resources Recommend Favorite

Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients

By Prescott I. A.   Dostrovsky J. O.   Moro E.   Hodaie M.   Lozano A. M.   Hutchison W. D.  

Brain, Vol. 132, Iss. 2, 2009-02 ,pp. : 309-318

Oxford University Press

Access to resources Recommend Favorite

Endogenous dopamine release in Parkinson's disease

By Rinne J.O.  

Lancet Neurology, Vol. 2, Iss. 8, 2003-08 ,pp. : 460-461

Elsevier

Access to resources Recommend Favorite

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

By Bezard E.   Gross C.E.   Brotchie J.M.  

Trends in Neurosciences, Vol. 26, Iss. 4, 2003-04 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P.   Gerlach M.   Double K. L.   Riederer P.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite